Paul Heffernan

773 total citations
14 papers, 481 citations indexed

About

Paul Heffernan is a scholar working on Economics and Econometrics, Strategy and Management and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paul Heffernan has authored 14 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Economics and Econometrics, 5 papers in Strategy and Management and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paul Heffernan's work include Innovation and Knowledge Management (5 papers), Firm Innovation and Growth (5 papers) and Pleural and Pulmonary Diseases (2 papers). Paul Heffernan is often cited by papers focused on Innovation and Knowledge Management (5 papers), Firm Innovation and Growth (5 papers) and Pleural and Pulmonary Diseases (2 papers). Paul Heffernan collaborates with scholars based in United Kingdom, Canada and Portugal. Paul Heffernan's co-authors include Elizabeth Garnsey, Erik Stam, Santhosh Thyagu, Han Ting Wang, Laveena Munshi, Glen Taylor, Michael E. Detsky, Rakesh Patel, Sangeeta Mehta and Bruno L. Ferreyro and has published in prestigious journals such as CHEST Journal, Intensive Care Medicine and Frontiers in Oncology.

In The Last Decade

Paul Heffernan

12 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Heffernan United Kingdom 5 307 269 188 131 62 14 481
Eric A. Nerlinger Germany 7 284 0.9× 414 1.5× 210 1.1× 106 0.8× 62 1.0× 12 550
Daniel Halvarsson Sweden 8 219 0.7× 306 1.1× 146 0.8× 69 0.5× 33 0.5× 12 433
Elefthérios Sapsalis Belgium 4 338 1.1× 250 0.9× 77 0.4× 158 1.2× 21 0.3× 6 431
Masatoshi Kato Japan 11 190 0.6× 227 0.8× 158 0.8× 123 0.9× 34 0.5× 20 393
Guy Gellatly Canada 11 81 0.3× 216 0.8× 96 0.5× 117 0.9× 20 0.3× 28 339
Robert Pitkethly United Kingdom 8 152 0.5× 138 0.5× 90 0.5× 195 1.5× 67 1.1× 13 371
Tyler Biggs United States 8 78 0.3× 196 0.7× 118 0.6× 67 0.5× 35 0.6× 9 330
Morten Steffensen Norway 7 230 0.7× 122 0.5× 128 0.7× 128 1.0× 49 0.8× 13 532
E. J. Reedy United States 9 152 0.5× 134 0.5× 108 0.6× 41 0.3× 16 0.3× 18 276
Eric Santor Canada 9 50 0.2× 179 0.7× 421 2.2× 94 0.7× 166 2.7× 19 607

Countries citing papers authored by Paul Heffernan

Since Specialization
Citations

This map shows the geographic impact of Paul Heffernan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Heffernan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Heffernan more than expected).

Fields of papers citing papers by Paul Heffernan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Heffernan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Heffernan. The network helps show where Paul Heffernan may publish in the future.

Co-authorship network of co-authors of Paul Heffernan

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Heffernan. A scholar is included among the top collaborators of Paul Heffernan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Heffernan. Paul Heffernan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Malone, Sarah, Kiyan Heybati, Jiawen Deng, et al.. (2025). Outcomes of high-flow versus conventional oxygen therapy in adult medical and post-surgical oncology patients: A systematic review and meta-analysis. Respiratory Medicine. 241. 108057–108057.
2.
Munshi, Laveena, Guillaume Dumas, Bram Rochwerg, et al.. (2024). Long-term survival and functional outcomes of critically ill patients with hematologic malignancies: a Canadian multicenter prospective study. Intensive Care Medicine. 50(4). 561–572. 9 indexed citations
3.
Patton, Laura, et al.. (2024). Hemophagocytic lymphohistiocytosis/cytokine release syndrome secondary to neoadjuvant pembrolizumab for triple-negative breast cancer: a case study. Frontiers in Oncology. 14. 1394543–1394543. 5 indexed citations
4.
Hanna, Nader M., A. Ménard, Ken R. Reid, et al.. (2021). Study protocol for DICE trial: Video-assisted thoracoscopic surgery decortication versus interventional radiology guided chest tube insertion for the management of empyema. Contemporary Clinical Trials Communications. 22. 100777–100777. 3 indexed citations
5.
Maxwell, S., et al.. (2020). A Tale of 2 Tubes for Emergency Management of Airway Obstruction From an Anterior Mediastinal Mass: A Case Report. A&A Practice. 14(10). e01257–e01257. 2 indexed citations
6.
Heffernan, Paul, et al.. (2019). Technology and Knowledge Based Business in the Cambridge Area; A review of the evidence. Apollo (University of Cambridge).
7.
Heffernan, Paul, et al.. (2016). A Case of Corynebacterium Striatum Disseminated Infection and Pneumonia in a Patient With Relapsed Acute Myeloid Leukemia. CHEST Journal. 150(4). 197A–197A. 2 indexed citations
8.
Theyel, Gregory, Glen Taylor, & Paul Heffernan. (2011). Bridging the gaps in industry evolution: Solar photovoltaic industry. 86. 1048–1052. 2 indexed citations
9.
Garnsey, Elizabeth & Paul Heffernan. (2007). The Cambridge High-Tech Cluster: An Evolutionary Perspective. Chapters. 1 indexed citations
10.
Heffernan, Paul. (2007). Constraints on the Growth of Technology-Based Firms – Perceptions and Effects. SSRN Electronic Journal. 2 indexed citations
11.
Garnsey, Elizabeth, Erik Stam, & Paul Heffernan. (2006). New Firm Growth: Exploring Processes and Paths. Industry and Innovation. 13(1). 1–20. 230 indexed citations
12.
Garnsey, Elizabeth & Paul Heffernan. (2005). Growth setbacks in new firms. Futures. 37(7). 675–697. 61 indexed citations
13.
Garnsey, Elizabeth & Paul Heffernan. (2005). High‐technology clustering through spin‐out and attraction: The Cambridge case. Regional Studies. 39(8). 1127–1144. 162 indexed citations
14.
Garnsey, Elizabeth & Paul Heffernan. (2003). Growth Setbacks in New Firms. SSRN Electronic Journal. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric A. Nerlinger Breakdown of academic impact, for papers by Daniel Halvarsson Breakdown of academic impact, for papers by Elefthérios Sapsalis Breakdown of academic impact, for papers by Masatoshi Kato Breakdown of academic impact, for papers by Guy Gellatly Breakdown of academic impact, for papers by Robert Pitkethly Breakdown of academic impact, for papers by Tyler Biggs Breakdown of academic impact, for papers by Morten Steffensen Breakdown of academic impact, for papers by E. J. Reedy Breakdown of academic impact, for papers by Eric Santor
Rankless by CCL
2026